Entering text into the input field will update the search result below

Endo International Presents at Morgan Stanley Global Healthcare Conference (Transcript)

SA Transcripts profile picture
SA Transcripts
145.52K Followers

Endo International Plc (ENDP) Morgan Stanley Global Healthcare Conference Call September 12, 2017 11:45 AM ET

Executives

Paul Campanelli – President and Chief Executive Officer
Blaise Coleman – Executive Vice President and Chief Financial Officer

Analysts

David Risinger – Morgan Stanley

David Risinger

So, thanks everybody for joining this session with Endo Pharmaceuticals. It’s very much my pleasure to welcome the CEO and CFO. I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures.

So with me, we have Paul Campanelli to my left, he’s the President and CEO. He became CEO in September2016. And prior to Endo he was CEO of Par Pharmaceuticals and he has a longstanding track record in the generic pharmaceutical industry of building companies and creating value. With respect to Blaise, Blaise Coleman is the CFO of Endo. He was named CFO a little bit less than a year ago. He’s been with Endo for 2.5 years and he has extensive experience as a financial executive.

So with that, I thought that I’d start off with a high level question. Obviously, there’s been a lot to manage at Endo, but it would be helpful before we go into details on what you accomplished recently and some of the opportunities ahead. Maybe just state your vision for Endo and how you want to build the company at a high level and then will come back to some more of the specifics on the execution.

Paul Campanelli

Sure. Thanks, Dave. So from a vision standpoint I think since I was asked to take on this role, we’ve been pretty candid and pretty direct, and we have a vision that we are driving toward. The first part has to do with the generic business. We’ve taken a very thoughtful, mindful approach with our portfolio and in playing in space that is tied to hard to make

Recommended For You

About ENDPQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

More on ENDPQ